All news

Teva EVP sells 20,003 shares, cuts stake 26.4%

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Teva Pharmaceutical Industries EVP Richard Daniell sold 20,003 shares of the company's stock for over $856,000, reducing his direct stake by 26.4%. This follows an earlier sale of 25,000 shares. The company recently surpassed quarterly earnings and revenue expectations, and analysts maintain a generally positive outlook with an average target price of $48.15.

Read original source

TEVA company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.